The Story Behind the Cover Picture
Leonardo da Vinci’s depiction of the liver
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:724-725
.
(01 October 2025)
Original Article
Technical performance, surgical workload and patient outcomes of robotic and laparoscopic surgery for pediatric choledochal cyst: a multicenter retrospective cohort and propensity score-matched study
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:726-741
.
(01 October 2025)
PDF
Full Text
(533)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Compared with LS, RS could provide better surgical technical performance in minimally invasive CC surgery, reduce the surgical workload of surgeons, and provide more satisfactory postoperative outcomes, especially with fewer postoperative anastomotic strictures.
Optimization of ALPPS stage II timing with the APRI/ALBI score—an international, multicenter cohort study
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:742-754
.
(01 October 2025)
PDF
Full Text
(325)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
Implementation of repeated APRI/ALBI score measurement leads to optimal timing of ALPPS stage II. Once the score normalized in the interstage phase and stage II was performed, only 3 % clinically relevant PHLF occurred.
Sarcopenia and gender disparities in liver transplant waiting lists: evaluating predictive scores and delisting risks
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:755-765
.
(01 October 2025)
PDF
Full Text
(241)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
The study evaluates different prioritization scores for liver transplantation, identifying GEMA-Na as the most accurate predictor for delisting. However, it overlooks the impact of sarcopenia, disproportionately affecting men. Incorporating sarcopenia into the scoring system is essential to prevent exacerbating gender disparities.
Laparoscopic versus robotic pancreaticoduodenectomy for distal cholangiocarcinoma after learning curves of surgeons: a multicenter propensity score-matched study
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:766-781
.
(01 October 2025)
PDF
Full Text
(312)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
This multicenter study demonstrates that both LPD and RPD are safe and feasible for DCC following the learning curve, with RPD consuming less operation time. However, no significant differences were observed in complications, oncological outcomes, or textbook outcomes. Further validation through randomized trials is recommended.
Development of scoring models to predict early pancreatic cancer risk in new-onset diabetes mellitus patients
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:782-794
.
(01 October 2025)
PDF
Full Text
(379)
Reporting Checklist
Data Sharing Statement
Peer Review File
COI Form
Open Access
New risk models to predict one- and three-year pancreatic risk among patients with new-onset diabetes mellitus among Asian populations have been developed. The high accuracy of the models allow potential clinical application for early detection of pancreatic cancer to improve prognosis.
Review Article
Neoadjuvant systemic therapy for hepatocellular carcinoma: challenges and opportunities—a narrative review
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:795-813
.
(01 October 2025)
Preoperative neoadjuvant therapy for hepatocellular carcinoma, comprising chemotherapy, targeted therapy, immunotherapy and combined therapy, can delay postoperative relapse and improve overall survival after liver resection or liver transplantation. Further research is needed to identify suitable candidates, predictive biomarkers, optimal regimens, and ideal timing for surgery.
French Editorial Commentary from the ACHBPT
From systematic adjuvant chemotherapy in pancreatic cancer to personalized adjuvant chemotherapy: is the PANAMA score the solution?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:814-816
.
(01 October 2025)
Editorial Commentary
Optimizing venous outflow reconstruction for V5 & V8 in right-lobe living-donor liver transplantation: “half-circumferential anastomosis” using autologous vein grafts
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:817-823
.
(01 October 2025)
Opportunistic case-finding of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD) by leveraging integrated care pathways of type 2 diabetes
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:824-828
.
(01 October 2025)
Integrating surgery into multimodal treatment for locally advanced pancreatic cancer: beyond the boundaries of systemic therapy
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:829-831
.
(01 October 2025)
Recognizing significant role of pancreatic anastomosis in improving clinical outcomes of patients after central pancreatectomy
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:832-834
.
(01 October 2025)
Optimization of outpatient care for patients with decompensated liver cirrhosis: a post-discharge nursing initiative improves quality of life
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:835-838
.
(01 October 2025)
Durvalumab plus cisplatin and gemcitabine in advanced biliary tract cancer: can we do it better?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:839-842
.
(01 October 2025)
The future of hepatobiliary surgical oncology
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:843-846
.
(01 October 2025)
Can artificial intelligence deliver on the promise of precision medicine?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:847-850
.
(01 October 2025)
Hypothermic oxygenated machine perfusion for ante-situm liver resection: a note of caution?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:851-856
.
(01 October 2025)
Biliary sphincterotomy for sphincter of Oddi disorder: is sphincterotomy cutting it?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:857-860
.
(01 October 2025)
Anthracycline selection in drug-eluting-beads-transarterial chemoembolization (DEB-TACE) for hepatocellular carcinoma: emerging evidence for idarubicin
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:861-864
.
(01 October 2025)
Second-line therapies in PBC-related cirrhosis: balancing efficacy and safety
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:865-868
.
(01 October 2025)
Resection and yttrium-90 radioembolization as sequential downstaging to living donor liver transplantation for large, multifocal hepatocellular carcinoma with lobar portal vein tumor thrombosis
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:869-873
.
(01 October 2025)
Integrating radiomics and 3D bioprinted tumor model: the next-generation approach to improve pancreatic cancer treatment
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:874-877
.
(01 October 2025)
Role of non-invasive tests in the management of resectable hepatocellular carcinoma: future directions
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:878-882
.
(01 October 2025)
Editorial
Reconciling diagnostic definitions for proposing metabolic dysfunction-associated steatotic liver disease in chronic kidney disease risk
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:883-888
.
(01 October 2025)
The challenge of sustaining therapeutic response in MASLD: insights from noninvasive liver assessment
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:889-891
.
(01 October 2025)
Laparoscopic surgery for gallbladder cancer: is skepticism still justified?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:892-894
.
(01 October 2025)
Letter to the Editor
Transarterial chemoembolization combined with immunotherapy plus bevacizumab or lenvatinib for the treatment of unresectable hepatocellular carcinoma: which treatment strategy demonstrates superior efficacy?
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:895-901
.
(01 October 2025)
Laparoscopic duodenum-preserving pancreatic head resection guided by the two-stage indocyanine green fluorescence imaging
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:902-905
.
(01 October 2025)
Images in Clinical Medicine
“Starry sky” liver: diffuse biliary hamartoma
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:906-907
.
(01 October 2025)
Rare case of leiomyomatosis peritonealis disseminata with hepatic involvement
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:908-910
.
(01 October 2025)
Portal hypertensive biliopathy secondary to Abernethy malformation mimicking a hepatic hilum mass
HepatoBiliary Surgery and Nutrition
2025;
14
(5)
:911-913
.
(01 October 2025)
